Cuba’s CimaVax Vaccine To Enter US Clinical Trials
In 2011, Cuban scientists contacted Roswell Park Cancer Institute to discuss a vaccine Havana’s Centro de Inmunologia Moleculogia Molecular (CIM) had developed for potential use in treating advanced stage lung cancer and other cancers. After discussions that focused on the science as well as building trust, CIM and Roswell Park entered into an R&D partnership … Read more